US Patent 8754090 Use of inhibitors of bruton's tyrosine kinase (Btk)
Patent 8754090 was granted and assigned to Pharmacyclics on June, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
David J. Loury0
Gwen Fyfe0
Joseph J. Buggy0
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08754090 Use of inhibitors of bruton's tyrosine kinase (Btk) US Patent 8754090 Use of inhibitors of bruton's tyrosine kinase (Btk)
Infobox
Patent Number
08754090
Patent Number
8754090
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08754090 Use of inhibitors of bruton's tyrosine kinase (Btk)
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08754090
Date of patent
June 17, 2014
Patent application number
13340522
Date Filed
December 29, 2011
Patent primary examiner
Find more entities like US Patent 8754090 Use of inhibitors of bruton's tyrosine kinase (Btk)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
